BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 25910559)

  • 1. Buffered l-ascorbic acid, alone or bound to KMUP-1 or sildenafil, reduces vascular endothelium growth factor and restores endothelium nitric oxide synthase in hypoxic pulmonary artery.
    Wu JR; Kao LP; Wu BN; Dai ZK; Wang YY; Chai CY; Chen IJ
    Kaohsiung J Med Sci; 2015 May; 31(5):241-54. PubMed ID: 25910559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
    Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
    Br J Pharmacol; 2010 Jun; 160(4):971-86. PubMed ID: 20590592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NO donor KMUP-1 improves hepatic ischemia-reperfusion and hypoxic cell injury by inhibiting oxidative stress and pro-inflammatory signaling.
    Kuo KK; Wu BN; Chiu EY; Tseng CJ; Yeh JL; Liu CP; Chai CY; Chen IJ
    Int J Immunopathol Pharmacol; 2013; 26(1):93-106. PubMed ID: 23527712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KMUP-1 inhibits H441 lung epithelial cell growth, migration and proinflammation via increased NO/CGMP and inhibited RHO kinase/VEGF signaling pathways.
    Wu BN; Chen HY; Liu CP; Hsu LY; Chen IJ
    Int J Immunopathol Pharmacol; 2011; 24(4):925-39. PubMed ID: 22230399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KMUP-1 inhibits hypertension-induced left ventricular hypertrophy through regulation of nitric oxide synthases, ERK1/2, and calcineurin.
    Yeh JL; Liu CP; Hsu JH; Tseng CJ; Wu PJ; Wang YY; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2012 Nov; 28(11):567-76. PubMed ID: 23140764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KMUP-1 ameliorates monocrotaline-induced pulmonary arterial hypertension through the modulation of Ca2+ sensitization and K+-channel.
    Dai ZK; Cheng YJ; Chung HH; Wu JR; Chen IJ; Wu BN
    Life Sci; 2010 May; 86(19-20):747-55. PubMed ID: 20303989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KMUP-1 inhibits pulmonary artery proliferation by targeting serotonin receptors/transporter and NO synthase, inactivating RhoA and suppressing AKT/ERK phosphorylation.
    Chung HH; Dai ZK; Wu BN; Yeh JL; Chai CY; Chu KS; Liu CP; Chen IJ
    Vascul Pharmacol; 2010; 53(5-6):239-49. PubMed ID: 20870034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β3 adrenergic agonism: A novel pathway which improves right ventricular-pulmonary arterial hemodynamics in pulmonary arterial hypertension.
    Karimi Galougahi K; Zhang Y; Kienzle V; Liu CC; Quek LE; Patel S; Lau E; Cordina RL; Figtree GA; Celermajer DS
    Physiol Rep; 2023 Jan; 11(1):e15549. PubMed ID: 36597221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled KMUP-1 Prevents Allergic Pulmonary Vascular Inflammation and Remodeling via NO and Suppressed MMP-9 and ICAM-1/VCAM-1.
    Liu CP; Hsieh CH; Wu BN; Yeh JL; Dai ZK; Chai CY; Chen IJ
    Inflamm Allergy Drug Targets; 2012 Aug; 11(4):251-61. PubMed ID: 22452605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iptakalim attenuates hypoxia-induced pulmonary arterial hypertension in rats by endothelial function protection.
    Zhu R; Bi LQ; Wu SL; Li L; Kong H; Xie WP; Wang H; Meng ZL
    Mol Med Rep; 2015 Aug; 12(2):2945-52. PubMed ID: 25936382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertension.
    Murata T; Kinoshita K; Hori M; Kuwahara M; Tsubone H; Karaki H; Ozaki H
    Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2335-42. PubMed ID: 16166567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Κ-opioid receptor stimulation improves endothelial function in hypoxic pulmonary hypertension.
    Wu Q; Wang HY; Li J; Zhou P; Wang QL; Zhao L; Fan R; Wang YM; Xu XZ; Yi DH; Yu SQ; Pei JM
    PLoS One; 2013; 8(5):e60850. PubMed ID: 23667430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.
    Peng G; Ivanovska J; Kantores C; Van Vliet T; Engelberts D; Kavanagh BP; Enomoto M; Belik J; Jain A; McNamara PJ; Jankov RP
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2599-611. PubMed ID: 22505643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Delivery of Sildenafil for Inhibiting Pulmonary Vascular Remodeling.
    Li B; He W; Ye L; Zhu Y; Tian Y; Chen L; Yang J; Miao M; Shi Y; Azevedo HS; Ma Z; Hao K
    Hypertension; 2019 Mar; 73(3):703-711. PubMed ID: 30636546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sildenafil inhibits hypoxia-induced pulmonary hypertension.
    Zhao L; Mason NA; Morrell NW; Kojonazarov B; Sadykov A; Maripov A; Mirrakhimov MM; Aldashev A; Wilkins MR
    Circulation; 2001 Jul; 104(4):424-8. PubMed ID: 11468204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of uridine 5'-triphosphate-suppressed delayed rectifying K
    Dai ZK; Kao CL; Hsieh SL; Chen IJ; Wu BN
    Kaohsiung J Med Sci; 2016 Dec; 32(12):607-613. PubMed ID: 27914611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
    Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
    J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAY 41-2272 inhibits the development of chronic hypoxic pulmonary hypertension in rats.
    Thorsen LB; Eskildsen-Helmond Y; Zibrandtsen H; Stasch JP; Simonsen U; Laursen BE
    Eur J Pharmacol; 2010 Nov; 647(1-3):147-54. PubMed ID: 20828552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
    Huh JW; Kim SY; Lee JH; Lee YS
    Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.